Literature DB >> 10761939

Charnley total hip arthroplasty with cement. Minimum twenty-five-year follow-up.

J J Callaghan1, J C Albright, D D Goetz, J P Olejniczak, R C Johnston.   

Abstract

BACKGROUND: This report presents the results of the senior author's initial twenty-five-year experience with the use of Charnley total hip arthroplasty with cement. The purpose of this paper was to evaluate the long-term results of total hip arthroplasty.
METHODS: Between July 1970 and April 1972, the senior author (R. C. J.) performed 330 Charnley total hip replacements with cement using a hand-packing cement technique in 262 patients. Fifty-one patients (sixty-two hips) who were alive at least twenty-five years post-operatively were evaluated from a clinical standpoint with use of a standard-terminology questionnaire. The average age of this group at the time of surgery was fifty-six years (range, thirty-five to seventy-one years) compared with sixty-five years (range, twenty-one to eighty-nine years) for the entire group. All patients were evaluated for radiographic changes at the time of their most recent follow-up. Of the fifty-one patients (sixty-two hips) who were alive at least twenty-five years postoperatively, thirty-one (thirty-six hips) had a follow-up radiograph made at a minimum of twenty-five years after the surgery. The average duration of radiographic follow-up for the fifty-one patients was 22.7 years (range, two to twenty-seven years).
RESULTS: Of the sixty-two hips in the fifty-one patients who were alive at least twenty-five years postoperatively, fourteen (23 percent) had been revised. Three (5 percent) had the revision because of loosening with infection; eleven (18 percent), because of aseptic loosening; and none, because of dislocation. The prevalence of revision due to aseptic loosening of the acetabular component in all 316 hips (excluding those that were lost to follow-up or that were revised for infection or dislocation) was 6 percent (eighteen hips), whereas the prevalence in the fifty-nine hips (excluding the three revised for infection) in the patients who were alive at least twenty-five years after the arthroplasty was 15 percent (nine hips). The prevalence of revision because of aseptic loosening of the femoral component in all 316 hips was 3 percent (nine hips), and the prevalence in the fifty-nine hips in the living patients was 7 percent (four hips). In the group of living patients, osteolysis occurred in Gruen zone 1 or 7 in thirty-three hips and in Gruen zones 2 through 6 in two hips. Ballooning acetabular osteolysis occurred in five hips. Of the 327 hips for which the outcome was known after a minimum of twenty-five years, 295 (90 percent) had retained the original implants until the patient died or until the most recent follow-up examination. Of the sixty-two hips in patients who lived for at least twenty-five years after the surgery, forty-eight (77 percent) had retained the original prosthesis.
CONCLUSIONS: Our follow-up study at twenty-five years following Charnley total hip arthroplasty with cement demonstrates the durability of the results of the procedure. These results should provide a means for comparison with the results of newer cementing techniques as well as those associated with newer cemented and cementless hip designs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761939     DOI: 10.2106/00004623-200004000-00004

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  41 in total

1.  Femoral cementing techniques: current trends in the UK.

Authors:  S K Nedungayil; S Mehendele; S Gheduzzi; I D Learmonth
Journal:  Ann R Coll Surg Engl       Date:  2006-03       Impact factor: 1.891

2.  A long-term follow-up study of the cementless THA with anatomic stem/HGPII cup with 22-mm head.

Authors:  Yutaka Nakoshi; Masahiro Hasegawa; Akihiro Sudo; Atsumasa Uchida
Journal:  Int Orthop       Date:  2008-01-09       Impact factor: 3.075

3.  Effect of proximal femoral osteoporosis on cementless hip arthroplasty: a short-term clinical analysis.

Authors:  Xian-feng Lou; Yu-hong Li; Xiang-jin Lin
Journal:  J Zhejiang Univ Sci B       Date:  2007-01       Impact factor: 3.066

Review 4.  Evidence-based computer-navigated total hip arthroplasty: an updated analysis of randomized controlled trials.

Authors:  Yu-Lin Li; Jun Jia; Qiang Wu; Guang-Zhi Ning; Qiu-Li Wu; Shi-Qing Feng
Journal:  Eur J Orthop Surg Traumatol       Date:  2013-04-16

5.  How are those "lost to follow-up" patients really doing? A compliance comparison in arthroplasty patients.

Authors:  Jung Keun Choi; Jeffrey A Geller; David A Patrick; Wenbao Wang; William Macaulay
Journal:  World J Orthop       Date:  2015-01-18

6.  Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study.

Authors:  A-K Nilsdotter; I F Petersson; E M Roos; L S Lohmander
Journal:  Ann Rheum Dis       Date:  2003-10       Impact factor: 19.103

7.  Endovascular embolisation is a successful and safe treatment for post-operative arterial complications after total hip arthroplasty and revision surgery.

Authors:  Matthias Erschbamer; Jürgen Den Hollander; Daniel Sauter; Johannes Erhardt; Lukas Hechelhammer; Fabrice Külling
Journal:  Int Orthop       Date:  2015-11-28       Impact factor: 3.075

8.  Total hip arthroplasty in patients younger than 21 years: a minimum, 10-year follow-up.

Authors:  Benoît J Bessette; François Fassier; Michael Tanzer; Caleb E Brooks
Journal:  Can J Surg       Date:  2003-08       Impact factor: 2.089

Review 9.  Minimally invasive and computer-navigated total hip arthroplasty: a qualitative and systematic review of the literature.

Authors:  Inge H F Reininga; Wiebren Zijlstra; Robert Wagenmakers; Alexander L Boerboom; Bregtje P Huijbers; Johan W Groothoff; Sjoerd K Bulstra; Martin Stevens
Journal:  BMC Musculoskelet Disord       Date:  2010-05-17       Impact factor: 2.362

10.  Clinical biomechanics of wear in total hip arthroplasty.

Authors:  John J Callaghan; Douglas R Pedersen; Richard C Johnston; Thomas D Brown
Journal:  Iowa Orthop J       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.